Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Knuth

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Oncoimmunology|December 25, 2012
Radiotherapy supports protective tumor-specific immunityAnurag Gupta, Anu Sharma, Lotta von Boehmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Cryptic epitopes induce high-titer humoral immune response in patients with cancerEliane Fischer, Sebastian Kobold, Sascha Kleber, et al.
Gynecologic Oncology|December 9, 2008
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II studyAkin Atmaca, Salah-Eddin Al-Batran, Antje Neumann, et al.
Health Affairs (Project Hope)|September 10, 2014
Challenges in adapting international best practices in cancer prevention, care, and research for QatarPeter J Howitt, Karen Kerr, Hanan Al Kuwari, et al.
Scientific Reports|June 30, 2021
The effect of protein mutations on drug binding suggests ensuing personalised drug selectionShunzhou Wan, Deepak Kumar, Valentin Ilyin, et al.
Case Reports in Oncology|April 29, 2011
Temsirolimus is highly effective as third-line treatment in chromophobe renal cell cancerDimitrios Zardavas, Alexander Meisel, Panagiotis Samaras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic headStefan Heinrich, Bernhard C Pestalozzi, Markus Schäfer, et al.
Pathology International|October 16, 2010
Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's diseaseOlivier Giger, Rosmarie Caduff, Alix O'Meara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2011
MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumorsPeter K Bode, André Barghorn, Florian R Fritzsche, et al.
Onkologie|June 29, 2007
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancerMarc Salzberg, Christoph Rochlitz, Rudolf Morant, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Oncoimmunology|December 25, 2012
Radiotherapy supports protective tumor-specific immunityAnurag Gupta, Anu Sharma, Lotta von Boehmer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 28, 2010
Cryptic epitopes induce high-titer humoral immune response in patients with cancerEliane Fischer, Sebastian Kobold, Sascha Kleber, et al.
Gynecologic Oncology|December 9, 2008
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II studyAkin Atmaca, Salah-Eddin Al-Batran, Antje Neumann, et al.
Health Affairs (Project Hope)|September 10, 2014
Challenges in adapting international best practices in cancer prevention, care, and research for QatarPeter J Howitt, Karen Kerr, Hanan Al Kuwari, et al.
Scientific Reports|June 30, 2021
The effect of protein mutations on drug binding suggests ensuing personalised drug selectionShunzhou Wan, Deepak Kumar, Valentin Ilyin, et al.
Case Reports in Oncology|April 29, 2011
Temsirolimus is highly effective as third-line treatment in chromophobe renal cell cancerDimitrios Zardavas, Alexander Meisel, Panagiotis Samaras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic headStefan Heinrich, Bernhard C Pestalozzi, Markus Schäfer, et al.
Pathology International|October 16, 2010
Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's diseaseOlivier Giger, Rosmarie Caduff, Alix O'Meara, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 23, 2011
MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumorsPeter K Bode, André Barghorn, Florian R Fritzsche, et al.
Onkologie|June 29, 2007
An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancerMarc Salzberg, Christoph Rochlitz, Rudolf Morant, et al.
Pageof 13